Recognition and prevention of hospital-associated enteric infections in the intensive care unit.

Critical Care Medicine
Linda D Bobo, Erik R Dubberke

Abstract

The objectives of this article were to review the causes and extent of hospital-associated infectious diarrhea and associated risks in the general hospital ward and intensive care unit (ICU), to compare microorganisms with similar symptoms to aid in recognition that will lead to timely and appropriate treatment and control measures, and to propose infection prevention protocols that could decrease human process errors in the ICU. This literature review describes epidemiology, comparison of microbial characteristics for potential hospital-associated enteric pathogens, diagnosis, and prevention, especially if important in the ICU, and particularly in regard to Clostridium difficile. Enteric organisms that most commonly cause hospital-associated infectious diarrhea in acute care settings and the ICU are C. difficile, rotavirus, and norovirus, although others may also be important, particularly in developing countries. To recognize and control infectious diarrhea successfully in the ICU, intensivists should be aware that epidemiology, risks, and prevention measures may differ between these microorganisms. In addition, intensivists should be ready to implement systems changes related to notification, isolation precautions and preven...Continue Reading

Associated Clinical Trials

References

May 1, 1979·The Journal of General Virology·M K EstesC P Gerba
Mar 9, 1978·The New England Journal of Medicine·J G BartlettA B Onderdonk
Jun 1, 1992·Journal of Clinical Microbiology·J R GentschM K Bhan
Oct 16, 1991·JAMA : the Journal of the American Medical Association·W C LevineR V Tauxe
Sep 1, 1991·Journal of Clinical Microbiology·R L WardG M Schiff
May 1, 1991·Reviews of Infectious Diseases·S A AnsariS A Sattar
Mar 1, 1991·The Pediatric Infectious Disease Journal·S NavarreteJ I Santos-Preciado
Sep 1, 1990·The American Journal of Tropical Medicine and Hygiene·E N JanoffD N Taylor
Apr 1, 1990·American Journal of Epidemiology·E L Ford-JonesM Petric
Jul 1, 1990·Antimicrobial Agents and Chemotherapy·H E Larson, S P Borriello
Oct 1, 1987·Journal of Clinical Microbiology·G W GaryA V Bartlett
Jan 26, 1989·The New England Journal of Medicine·L V McFarlandW E Stamm
Aug 1, 1986·The Journal of Hygiene·N Lloyd-EvansS A Sattar
May 1, 1987·Reviews of Infectious Diseases·D B Hrdy
Feb 1, 1987·American Journal of Diseases of Children·A KovacsB Portnoy
May 1, 1985·Annals of Internal Medicine·K L KochW L Current
Apr 11, 1974·The New England Journal of Medicine·F J TedescoD H Alpers
Jul 1, 1980·The Journal of Pediatrics·F T SaulsburyR H Yolken
Jan 1, 1981·Journal of Medical Virology·Y SakumaT Nakao
Jan 1, 1983·Critical Care Medicine·T W KellyK M Hillman
Jun 1, 1982·Australian and New Zealand Journal of Medicine·B A WaltersE Seneviratne
Feb 1, 1981·The American Journal of Medicine·W E StammR E Dixon
Jul 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W R MacKenzieJ P Davis
Jan 1, 1995·Archives of Virology·X JiangM K Estes
May 1, 1995·The Journal of Clinical Investigation·M RieglerJ T LaMont
Apr 1, 1994·The Journal of Hospital Infection·P R Chadwick, R McCann
Aug 1, 1993·Journal of Clinical Microbiology·K FanL B Reller
Jan 1, 1996·The Journal of Infectious Diseases·C L ChappellH L DuPont
Jul 1, 1996·Journal of Clinical Microbiology·A B BalatbatJ Silva
Oct 3, 1996·The New England Journal of Medicine·F R VelázquezG M Ruiz-Palacios
Oct 14, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L S KimJ Koch
Oct 20, 1998·The Journal of Hospital Infection·G E Bignardi

❮ Previous
Next ❯

Citations

Jul 13, 2012·Journal of Clinical Microbiology·Matthias F C BeersmaMarion Koopmans
Feb 26, 2011·American Journal of Infection Control·Rada ShakovVincent A DeBari
Aug 5, 2010·Critical Care Medicine·Jan E PattersonLisa L Maragakis
May 24, 2015·The Journal of General Virology·James Ayukepi AyukekbongTomas Bergström
Jun 28, 2011·The Journal of Molecular Diagnostics : JMD·Kimberle C ChapinSarah B Andrea
Feb 19, 2015·Current Opinion in Critical Care·Annika Reintam BlaserSonja Fruhwald
Oct 11, 2016·Intensive & Critical Care Nursing : the Official Journal of the British Association of Critical Care Nurses·Giuseppe BattistellaStefania Bazzo
Nov 4, 2016·The American Journal of Gastroenterology·David M FaleckDaniel E Freedberg
Jun 12, 2013·Journal of Intensive Care Medicine·J T Higa, C P Kelly
Jan 2, 2021·Risk Analysis : an Official Publication of the Society for Risk Analysis·G F AkpeimehI E Ibanga

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.